Literature DB >> 21135220

Impaired induction of DNA lesions during immunoglobulin class-switch recombination in humans influences end-joining repair.

Sven Kracker1, Kohsuke Imai, Pauline Gardès, Hans D Ochs, Alain Fischer, Anne H Durandy.   

Abstract

Ig class-switch recombination (CSR) is a region-specific process that exchanges the constant Ig heavy-chain region and thus modifies an antibody's effector function. DNA lesions in switch (S) regions are induced by activation-induced cytidine deaminase (AID) and uracil-DNA glycosylase 2 (UNG2), subsequently processed to DNA breaks, and resolved by either the classical nonhomologous end-joining pathway or the alternative end-joining pathway (XRCC4/DNA ligase 4- and/or Ku70/Ku80-independent and prone to increased microhomology usage). We examined whether the induction of DNA lesions influences DNA end-joining during CSR by analyzing Sμ-Sα recombination junctions in various human Ig CSR defects of DNA lesion induction. We observed a progressive trend toward the usage of microhomology in Sμ-Sα recombination junctions from AID-heterozygous to AID-autosomal dominant to UNG2-deficient B lymphocytes. We thus hypothesize that impaired induction of DNA lesions in S regions during CSR leads to unusual end-processing of the DNA breaks, resulting in microhomology-mediated end-joining, which could be an indication for preferential processing by alternative end-joining rather than by classical nonhomologous end-joining.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135220      PMCID: PMC3009794          DOI: 10.1073/pnas.1012591108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Genomic instability in mice lacking histone H2AX.

Authors:  Arkady Celeste; Simone Petersen; Peter J Romanienko; Oscar Fernandez-Capetillo; Hua Tang Chen; Olga A Sedelnikova; Bernardo Reina-San-Martin; Vincenzo Coppola; Eric Meffre; Michael J Difilippantonio; Christophe Redon; Duane R Pilch; Alexandru Olaru; Michael Eckhaus; R Daniel Camerini-Otero; Lino Tessarollo; Ferenc Livak; Katia Manova; William M Bonner; Michel C Nussenzweig; André Nussenzweig
Journal:  Science       Date:  2002-04-04       Impact factor: 47.728

2.  SnapShot: Nonhomologous DNA end joining (NHEJ).

Authors:  Michael R Lieber; Thomas E Wilson
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

3.  AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching.

Authors:  Michel C Nussenzweig; André Nussenzweig; Simone Petersen; Rafael Casellas; Bernardo Reina-San-Martin; Hua Tang Chen; Michael J Difilippantonio; Patrick C Wilson; Leif Hanitsch; Arkady Celeste; Masamichi Muramatsuk; Duane R Pilch; Christophe Redon; Thomas Ried; William M Bonner; Tasuku Honjo
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

4.  Alternative end joining during switch recombination in patients with ataxia-telangiectasia.

Authors:  Qiang Pan; Corinne Petit-Frére; Aleksi Lähdesmäki; Hanna Gregorek; Krystyna H Chrzanowska; Lennart Hammarström
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

5.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

6.  In situ class switching and differentiation to IgA-producing cells in the gut lamina propria.

Authors:  S Fagarasan; K Kinoshita; M Muramatsu; K Ikuta; T Honjo
Journal:  Nature       Date:  2001-10-11       Impact factor: 49.962

7.  AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.

Authors:  Svend K Petersen-Mahrt; Reuben S Harris; Michael S Neuberger
Journal:  Nature       Date:  2002-07-04       Impact factor: 49.962

8.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

9.  Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Smu region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation.

Authors:  Hitoshi Nagaoka; Masamichi Muramatsu; Namiko Yamamura; Kazuo Kinoshita; Tasuku Honjo
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

10.  Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.

Authors:  Carol E Schrader; Joycelyn Vardo; Janet Stavnezer
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  19 in total

Review 1.  Immunoglobulin class-switch DNA recombination: induction, targeting and beyond.

Authors:  Zhenming Xu; Hong Zan; Egest J Pone; Thach Mai; Paolo Casali
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

Review 2.  Complex regulation and function of activation-induced cytidine deaminase.

Authors:  Janet Stavnezer
Journal:  Trends Immunol       Date:  2011-04-13       Impact factor: 16.687

3.  Elucidation of IgH 3' region regulatory role during class switch recombination via germline deletion.

Authors:  Alexis Saintamand; Pauline Rouaud; Faten Saad; Géraldine Rios; Michel Cogné; Yves Denizot
Journal:  Nat Commun       Date:  2015-05-11       Impact factor: 14.919

Review 4.  Activation-induced cytidine deaminase in antibody diversification and chromosome translocation.

Authors:  Anna Gazumyan; Anne Bothmer; Isaac A Klein; Michel C Nussenzweig; Kevin M McBride
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

5.  Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint.

Authors:  Tineke Cantaert; Jean-Nicolas Schickel; Jason M Bannock; Yen-Shing Ng; Christopher Massad; Fabien R Delmotte; Natsuko Yamakawa; Salome Glauzy; Nicolas Chamberlain; Tuure Kinnunen; Laurence Menard; Aubert Lavoie; Jolan E Walter; Luigi D Notarangelo; Julie Bruneau; Waleed Al-Herz; Sara Sebnem Kilic; Hans D Ochs; Charlotte Cunningham-Rundles; Mirjam van der Burg; Taco W Kuijpers; Sven Kracker; Hideo Kaneko; Yujin Sekinaka; Shigeaki Nonoyama; Anne Durandy; Eric Meffre
Journal:  J Clin Invest       Date:  2016-10-04       Impact factor: 14.808

6.  AID recruits UNG and Msh2 to Ig switch regions dependent upon the AID C terminus [corrected].

Authors:  Sanjay Ranjit; Lyne Khair; Erin K Linehan; Anna J Ucher; Mrinmay Chakrabarti; Carol E Schrader; Janet Stavnezer
Journal:  J Immunol       Date:  2011-07-29       Impact factor: 5.422

7.  C-terminal region of activation-induced cytidine deaminase (AID) is required for efficient class switch recombination and gene conversion.

Authors:  Somayeh Sabouri; Maki Kobayashi; Nasim A Begum; Jianliang Xu; Kouji Hirota; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

8.  Differential regulation of S-region hypermutation and class-switch recombination by noncanonical functions of uracil DNA glycosylase.

Authors:  Ashraf S Yousif; Andre Stanlie; Samiran Mondal; Tasuku Honjo; Nasim A Begum
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

9.  Activation induced deaminase C-terminal domain links DNA breaks to end protection and repair during class switch recombination.

Authors:  Astrid Zahn; Anil K Eranki; Anne-Marie Patenaude; Stephen P Methot; Heather Fifield; Elena M Cortizas; Paul Foster; Kohsuke Imai; Anne Durandy; Mani Larijani; Ramiro E Verdun; Javier M Di Noia
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

10.  Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID.

Authors:  Marcel Kuhny; Lisa R Forbes; Elif Çakan; Andrea Vega-Loza; Valentyna Kostiuk; Ravi K Dinesh; Salomé Glauzy; Asbjorg Stray-Pedersen; Ashley E Pezzi; I Celine Hanson; Alexander Vargas-Hernandez; Mina LuQuing Xu; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Ivan K Chinn; David G Schatz; Jordan S Orange; Eric Meffre
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.